To better understand these interactions in the context of immunotherapy, we further analyzed our spatial transcriptomics data, which showed a higher degree of MIF-CXCR4 co-localization in post-treatment tumor of non-responder (Figure 4G), suggesting that this interaction may be linked to immunotherapy resistance. Here, MIF is linked to neoplasm.